Naprosyn Ec (Naproxen)

Naproxen, marketed as Naprosyn Ec, is an NSAID that alleviates pain and inflammation across several musculoskeletal and gynecologic conditions.

• Pain: Provides relief from mild to moderate acute pain such as dental, postoperative or musculoskeletal discomfort.
• Inflammation: Reduces swelling and inflammatory response in conditions like osteoarthritis and rheumatoid arthritis.
• Arthritis: Improves joint function and decreases stiffness associated with osteoarthritis and rheumatoid arthritis.
• Dysmenorrhea: Alleviates menstrual cramps and associated pelvic pain in primary dysmenorrhea.

• Naproxen exerts its effect by reversibly inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, which are key in the conversion of arachidonic acid to prostaglandins. By decreasing prostaglandin synthesis, it lowers the inflammatory mediators that cause pain, fever and swelling. This inhibition is dose‑dependent and occurs throughout the body, affecting peripheral tissues and the central nervous system, thereby providing systemic analgesic and antipyretic actions.

Naproxen may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Gastrointestinal discomfort such as nausea, dyspepsia, abdominal pain or heartburn.
• Headache or mild dizziness, occasionally accompanied by visual disturbances.
• Skin rash, pruritus or mild erythema, typically transient.

Serious or Rare Side Effects

• Gastrointestinal bleeding, ulceration or perforation, which may present with melena or hematemesis.
• Cardiovascular events including myocardial infarction, stroke or worsening of hypertension.
• Severe cutaneous reactions such as Stevens‑Johnson syndrome, toxic epidermal necrolysis or drug‑induced rash with systemic symptoms.

When prescribing naproxen, clinicians should consider several precautionary measures to minimize risks.

• Assess gastrointestinal risk: evaluate history of ulcers, bleeding or concurrent NSAID use.
• Evaluate cardiovascular status: consider existing heart disease, hypertension or stroke risk.
• Monitor renal function: check baseline kidney parameters, especially in elderly or dehydrated patients.
• Use lowest effective dose: limit duration to the shortest period necessary for symptom control.
• Avoid in known hypersensitivity: discontinue if allergic reactions such as rash or bronchospasm occur.
• Store at room temperature: keep tablets in the original container, protect from moisture and heat.

Naproxen can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
• Other NSAIDs or aspirin: additive gastrointestinal toxicity.
• Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding risk.

Moderate Interactions (Monitor Closely)

• Diuretics: may reduce renal clearance of naproxen.
• ACE inhibitors or ARBs: potential for reduced antihypertensive effect and renal impairment.
• Alcohol: can exacerbate gastrointestinal irritation and bleeding.